Humanized antibodies that recognize beta amyloid peptide
US7582733B2 · kind B2 · utility
45Cited by
164References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 30, 2002 |
| Grant date | Sep 1, 2009 |
| Priority date | — |
| Expiry date | Aug 30, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.